Resveratrol Supplement Market Size, Share, Opportunities, And Trends By Type (Anti-aging, Anti-inflammatory, Others), By Extract (Fermented, Synthetic), By Form (Powder, Liquid), And By Geography - Forecasts From 2023 To 2028

The resveratrol supplement market is projected to show steady growth during the forecast period.

Resveratrol supplements, derived from natural sources like red grapes, red wine, peanuts, and berries, have garnered attention for their potential health benefits, particularly due to the presence of the antioxidant compound resveratrol. The potential benefits of resveratrol are multifaceted. Acting as a potent antioxidant, it plays a crucial role in scavenging harmful free radicals, thereby protecting cells from oxidative damage. Studies also suggest that resveratrol may contribute to cardiovascular health by improving blood flow, reducing inflammation, and lowering levels of bad cholesterol. These effects are key factors in supporting a healthy heart and circulatory system.

Moreover, resveratrol supplements offer a holistic approach to health, encompassing antioxidant protection, cardiovascular support, neuroprotection, anti-inflammatory benefits, and potential metabolic advantages. It is essential for individuals considering resveratrol supplementation to choose high-quality products and consult with healthcare professionals to ensure safe and effective integration into their health regimen.

Market Drivers

• Anti-aging properties

The fascination with aging fuels a growing interest in resveratrol, attributed to its potential antioxidant and anti-inflammatory properties that could contribute to longevity and disease prevention. The rapid increase in the aging population has become a significant concern due to its implications for various chronic diseases. Resveratrol is naturally present in various foods like grapes, red wine, peanuts, and blueberries. Numerous studies have highlighted resveratrol's diverse bioactivities, encompassing antioxidant, anti-inflammatory, cardiovascular protection, anticancer, antidiabetes mellitus, antiobesity, neuroprotection, and antiaging effects. These studies indicate that resveratrol's antiaging mechanisms primarily involve ameliorating oxidative stress, relieving inflammatory reactions, improving mitochondrial function, and regulating apoptosis. As a result, resveratrol emerges as a promising and safe compound for both the prevention and treatment of ageing and age-related diseases. This multifaceted profile positions resveratrol supplements as a significant market driver.

• Growing elderly population

The global surge in the elderly population, coupled with demographic shifts, is fueling the demand for healthcare services and the resveratrol supplement market. In India, there has been a gradual increase in the elderly population, constituting 8.6% of the total population aged 60 and above, according to the 2011 census. Projections indicate that this figure is poised to exceed 10% by 2020. The decadal growth rate of the elderly population between the 2001 and 2011 censuses marked an upward trend for the first time since independence.In the United States, the population aged 65 and over has experienced a notable expansion, reaching 55.8 million or 16.8% of the total population in 2020. This demographic shift signals an aging population, correlating with a higher prevalence of health conditions that may require medical interventions and supplements. In Europe, the dependency ratio, measuring the number of elderly individuals in the working-age population, is projected to rise significantly by 2100. This indicates a larger proportion of elderly individuals who may require healthcare services. As the aging population grows, there is an anticipated increase in the demand for healthcare services, with a particular focus on the potential benefits of resveratrol in protecting brain cells from neurodegenerative diseases like Alzheimer's and Parkinson's. This aspect attracts significant interest, especially among aging populations.

Market Challenges

• Lack of studies and research-

Despite the considerable progress made in understanding the pharmacology of resveratrol (RV), the confirmation of its therapeutic efficacy in humans remains a pivotal challenge requiring more in-depth research. The pharmaceutical industry faces a significant hurdle in translating this compound for clinical use. Comprehensive investigations into its bioavailability, metabolic pathways, and human toxicity are imperative, highlighting the pharmaceutical sector's need to delve deeper into commercial medicinal production. Addressing these challenges is crucial for advancing the field of clinical medicine and elevating resveratrol to a level where it can be applied in mainstream medicine. The existing uncertainties may cast doubts among consumers seeking evidence-supported solutions for their health concerns.

The resveratrol supplement market is segmented into- fermented resveratrol and synthetic resveratrol

The market is segmented mainly into: fermented resveratrol and synthetic resveratrol. The fermented resveratrol variant is derived from natural sources such as grapes, berries, and peanuts.  Fermented resveratrol is noted for its potential advantages, including potentially better absorption and the presence of additional bioactive compounds from natural sources. Synthetic resveratrol produced in a laboratory setting through chemical synthesis, synthetic resveratrol offers a consistent and predictable dose of trans-resveratrol, a key component of resveratrol with known health benefits. This predictability can be crucial in applications where precise dosage is essential.

North America is anticipated to hold a significant share of the resveratrol supplement market.

North America is projected to account for a notable share of the resveratrol supplement market. An increasing health-consciousness among consumers in the region propels the demand for natural products such as resveratrol, sought after for its preventive health benefits and potential anti-aging properties. The prevalence of chronic diseases like cardiovascular conditions, diabetes, and neurodegenerative disorders in North America further accentuates the appeal of natural solutions, with resveratrol emerging as a promising candidate. In the United States specifically, the demographic aged 50 years and older is projected to experience a substantial surge of 61.11%, soaring from 137.25 million in 2020 to 221.13 million in 2050. Simultaneously, chronic diseases within this age group are anticipated to witness a staggering escalation of 99.5%, reaching 142.66 million by 2050. Notably, heart disease, impacting over 79 million Americans, holds significant sway, contributing to 40% of all deaths in the region.

Market Developments

• June 2023 -  Genetically modified (GM) yeast-fermented trans-resveratrol received approval for use in dietary supplements in Taiwan. The Taiwan Food and Drug Administration provided guidelines for the use and labelling of this specific type of trans-resveratrol. According to the regulations, the substance was classified as a dietary supplement, provided that the daily adult dose does not exceed 150 micrograms.
• November 2023 - Evolva and Breko broadened their partnership through an exclusive distribution agreement for Veri-teTM Resveratrol. Evolva, a pioneer in natural molecules and industrial biotech, and Breko GmbH, based in Bremen, Germany, a prominent supplier for the food and beverage industry, as well as functional foods, food supplements, and cosmetic products, formalized this exclusive distribution arrangement.
• May 2021 -  VINIA® was the first and only product in the world containing Piceid Resveratrol from red grapes at levels in each 400mg capsule of VINIA® equivalent to an average bottle of red wine, providing the benefits of red wine.

Company Products

• Youtheory Resveratrol - Youtheory Resveratrol introduces a proprietary super-fruit blend crafted to enhance antioxidant protection. The product features trans-resveratrol, a key component that helps neutralize free radicals, contributing to overall well-being and supporting the ageing process. With high bioavailability, these tablets are formulated for optimal effectiveness.
• Resveratrol(EZ Melts) - This product is designed to provide advanced antioxidant protection, supporting overall cardiovascular health. It leverages the benefits of red wine polyphenols to promote healthy ageing. Formulated for convenient use, it quickly dissolves in the mouth, eliminating the need for chewing or adding water. Importantly, it contains zero sugar, making it a health-conscious choice.
• RESVERATROL 100MG -  Formulated with ResVida™ and grape skin extract, this product is designed to enhance cardiovascular health by specifically supporting the well-being of blood vessels and endothelial function. With a focus on promoting healthy aging, it contributes to overall blood vessel health and helps maintain their optimal function. Additionally, the product provides powerful antioxidant protection, making it a comprehensive solution for cardiovascular well-being.

Market Segmentation

• By Type
  • Anti-aging
  • Anti-inflammatory
  • Others
• By Extract
  • Fermented
  • Synthetic
• By Form
  • Powder
  • Liquid
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. RESVERATROL SUPPLEMENT MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Anti-aging

5.3. Anti-inflammatory

5.4. Others

6. RESVERATROL SUPPLEMENT MARKET BY EXTRACT

6.1. Introduction

6.2. Fermented

6.3. Synthetic

7. RESVERATROL SUPPLEMENT MARKET BY FORM

7.1. Introduction

7.2. Powder

7.3. Liquid

8. RESVERATROL MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

10.1. Nutrawise Health & Beauty

10.2. Endurance Products Company

10.3. Pure Encapsulations,

10.4. Walgreen Co.

10.5. Life Extension

10.6. Nora Ross

10.7. iHerb, LLC.

10.8.  PureBulk

10.9. Carlyle Nutritionals, LLC

10.10. EZ Melts

Nutrawise Health & Beauty

Endurance Products Company

Pure Encapsulations,

Walgreen Co.

Life Extension

Nora Ross

iHerb, LLC.

PureBulk

Carlyle Nutritionals, LLC

EZ Melts